INTRA-UTERINE INJECTIONS OF STERILE GLYCERINE.
(a) PROPHYLAXIS.-I have found the above method of particular value as a prophylactic measure in suspicious cases. The healing properties of glycerine are widely appreciated; and, when following labour, the raw inner surface of the uterus is treated with sterile glycerine, it recovers its normal healthy condition much more readily.
(b) CURATIVE.-Here the glycerine treatment, in order to be of real value, must be employed very early in the disease. Glycerine, as a local method of treatment, is applicable to local infections. By promoting a free flow of lymph from the uterine wall into the uterine cavity, it produces a "lavage a retro," by which infecting bacteria are washed away; and the lymph possesses bactericidal properties. In a virulent infection, such as that associated with the streptococcus haemolyticus, the local defence may well be overcome before local measures can be afforded a proper chance, and hence the glycerine treatment would not be advised in such cases as an exclusive method of treatment.
TREATMENT BY DRUGS.
Drugs having reputed bactericidal action are numerous, but experience does not, even when the chemical agent is exploited generously and by the intravenous route, justify any degree of confidence in them. 86
(a) QUININE.-The use of quinine has been recommended in septicamia, largely from a belief in its antiseptic action in the blood. In this connection it has to be remarked that the microbes of septic fever are much more resistant to the action of quinine outside the body than are the protozoa, and the question therefore arises whether the blood and tissues are not liable to be seriously injured by the-quantity of quinine required to act upon the parasites they contain. Sir William Whitla says of quinine that "one grain in four ounces will destroy the white corpuscles of fresh human blood." Dr. Cushny points out that in many cases of septicaemia, where successful results have been claimed from quinine, the dose was far too small to be capable of acting either on the temperature or on the microbe. He also mentions that the reputed action of quinine in retarding tissue waste has now been proved to be erroneous. At Belfast Infirmary we gave quinine an extensive trial as a bactericide in early cases of puerperal streptococcal septicaemia. The results were disappointing, and did not at all encourage us to advocate quinine as an exclusive method of treatment in this disease. We formed the opinion that this drug, even when administered in large therapeutic doses and regularly repeated during the twenty-four hours, is not a sufficiently strong therapeutic agent to overcome virulent haemolytic streptococci in the blood-stream, where, it should be added, their powers of speedy multiplication and toxin elaboration are only too well known. Since we have already seen that massive doses cannot be recommended because of the serious risks involved, there is little use in persevering with this remedy as a curative measure in puerperal streptococcal septicmmia.
As a p,rophylactic in suspicious cases, some authorities recommend quinine grs. 7i
with anti-streptococcal serum (20 c.c.).
(b) COLLOIDAL SILVER.-The employment of this drug is based upon its antiseptic properties. It is administered by the intramuscular route, and it represents one of the modern methods of treatment in puerperal streptococcal infection. Sir Thomas Horder states that it has yielded "some apparent good results," but he considers it as still on probation.
We (a) ANTIBACTERIAL SERA.-These are subdivided into two classes-polyvalent and univalent. In deciding as to the value of an appropriate antibacterial serum in the treatment of puerperal streptococcal septicaemia, we have not only to examine into the nature of the serum used, but also into that of the septicaemia. First of all, the toxins produced by haemolytic streptococci are, as we have already seen, of the exogenous variety, and hence may be absorbed into the circulation apart from the streptococci which elaborate them, thus giving rise to the conditioni of exotoxwmia. Now, in puerperal streptococcal infection, a dose of anti-streptococcal serum will only be accessible to the infectinig streptococci when they succeed in entering the blood-stream. By the time this occurs, however, there will frequently be encountered a well-marked exotoxaemia. In this connection it is important to remember that exotoxins in the circulation are little affected by an antibacterial serum; and the only type of serum by which thev can successfully be neutralized is a suitable antitoxic one, a(dministered at the proper time. Hence, we can expect little from an anti-streptococcal serum in the matter of neutralizinig the exotoxins produced in puerperal streptococcal sepsis. lhe most we can expect from such an antibacterial serum is a destructioni of the organisms against which it is prepared, this action depending upon two conditions, namely, its degree of potency as an appropriate bactericidc, an(l the day of illness upon which the trcatment commences. Assuminig that the latter is sufficienitly early to give the serum a fair chance, then the success of the treatment will (lepend upon its bactericidal power. That is to say, the potency of such a serum as a bactericide will then measure its value as a method of treatment. Actually, what is this value? Sir Thomas Horder and Dr. John Matthews, referring to antibacterial sera generally, write: "By none of the metho(ds yet employed have these sera been producedl with a sufficicnitly rich contelnt of antibody to lead to any uniformly good results."
POLYVALENT SERA. -Streptococci generally, as we know, exist in groups, and anl anti-streptococcal serum preparedl against onic group is not by any means specific in respect of antibody for another group. It was therefore with the express object of overcoming this difficulty that a polyvalent anti-streptococcal serum was produced, the idea being that no matter to what group the infecting streptococc; belonged-hlemolytic or otherwise-it would be met by the polyvalent serum. The attempt, however, as Sir Thomas Horder tells us, "has not proved successful."
At Belfast Infirmary we gave polyvalent anti-streptococcal serum a very fair and extensive trial, anid I regret to say that the results obtained were very disappointing, the dceath-rate being little affected. It has to be remembered that only one group of streptococci is involved in the particular form of puerperal sepsis under consideration, namely, the hawmolytic group-the most virulent group of all. So, when we use a polyvalent serum in the treatment of this disease, we are using one of whose potency only a certain proportion is directed against the streptococcal group concerned. For this reason, in addition to those already given, I am not disposed to advocate the employment of such a serum as an effective method of treatment in puerperal streptococcal sepsis.
UNIVALENT SERA.-In comparison with the last type, a univalent streptococcus haemolyticus serum is much to be preferred, because it is concentrated against one particular group of streptococci, and that the one involved in puerperal streptococcal septicaemia. Sir Thomas Horder observes that in the case of streptococcal infections a univalent streptococcus pyogenes serum has been available for some years as the result of suggestions put forward by Andrewes and Horder. We have always to remember, however, that, at the best, a concentrated, univalent, streptococcus haemolyticus serum is an antibacterial one, and as such is not prepared to neutralize exotoxins, the variety predominating in puerperal streptococcal sepsis.
(b) ANTITOXIN SERA.-I have found anti-scarlatinal serum an excellent antitoxin serum in the treatment of puerperal streptococcal sepsis. To a series of twenty-two cases at the Belfast Infirmary, whose intra-uterine swabs each demonstrated the presence of haemolytic streptococci, we administered anti-scarlatinal serum with remarkably good results, which I tabulate at the end of this section.
And why, we ask, should anti-scarlatinal serum effect these results? Because the aetiological streptococcus in puerperal streptococcal septicaemia and scarlet fever each belongs to the same group-the hwmolytic group-and each of them produces an identical toxin, the Dick toxin. Hence, a serum successful in neutralizing the toxin of scarlatina must necessarily have a similar effect upon the toxin produced in puerperal streptococcal sepsis.
How Prepared.-Based on the work of the Dicks relative to the zetiological relationship of a certain type of the streptcoccus hwamolyticus to scarlet fever, this antitoxin is prepared as follows: Horses are inoculated with gradually increasing doses of toxin obtained from cultures of streptococci recently isolated from patients suffering from scarlatina in a severe form, and in due time bled (1) (2) 3. Aniaphylactic Precautions.-Before administering a dose of antitoxin, whether as a prophylactic or a curative measure, it is of the greatest importance to ascertain whether or not the patient requires to be desensitized, and to act accordingly. Thus, in patients giving a history of one or other of the specific fevers, or, apart from the latter, of having had a previous dose of serum at an interval of ten or more days, the following skin test should be carried out: "A small quantity, say 0.25 c.c., of normal horse serum (or antitoxin) is injected intradermally or rubbed into a scarified surface. There occurs, if anaphylaxis-or a toxic idiopathy to horse substanceexist, an urticurial patch sometimes progressing to a vesicular eruption with a surrounding area of erythema. This occurs usually within half an hour, but is occasionally delayed. If anaphylaxis be demonstrated, the patient should be desensitized. " 4. Mode of Administration.-Intramuscularly and very slowly. 5. Best Time to Administer.-Immediately after third stage of labour. In the presence of a septic focus, for example, an immediate dose will assist in neutralizing toxins that are being absorbed therefrom, and will reinforce the system's defence at a time when the patient's resistance is frequently diminished.
6. Prophylactic Cases.-The following cases, with the addition of one other, represent all those with whom I have tried anti-scarlatinal serum as a prophylactic measure. They seemed to me to be candidates for puerperal sepsis, which, after serum administration, did not develop in any of them.
(a) Macerated hydrocephalic monster. Faetus very foul-smelling, followed by decomposed placenta. Prophylactic dose of anti-scarlatinal serum was given immediately after third stage. Subsequently there occurred no elevation in temperature or other manifestation of septic infection. 99°F and 90 respectively for a period of twelve hours, or have recurred after an interval of twenty-fours hours from their initial rise. Reason: Because it is at this stage of the disease that anti-scarlatinal serum will be found most effective in neutralizing the toxins elaborated by the infecting streptococci. The consequences of such early neutralization are of very great importance to the patient concerned, and include the preservation from irreparable damage of the cardiac muscle and other tissues for which the streptococcus haemolyticus has a special affinity. Hence the work of the leucocytes in augmentinig the local resistance and ingesting streptococci which may be encountered in the circulation is not being undermined by an exogenous poisoning of the vital body tissues.
4. When to Repeat.-Twelve hours after the first injection, if the pulse and temperature have not shown an appreciable diminution.
5. Anaphylactic Precauttions.-Ill my experienlce it is most decidedly the exceptioni for a patient to require a dose of anti-scarlatinal serum at so great an interval as ten days from the date of the first injection, if the latter has been administered reasonably early in the disease. Such an exception would necessitate due observance of the anaphylactic precautions discussed under "prophylactic administration." It has been pointed out in the "British Medical Journal" that anaphylactic shock may occur with a third dose of serum, if administered after an interval of more than ten days from the date of the initial dose.
6. TVhen anti-scairlatinal serutm is too late to yield s(atisfactory resallts: When hoemolytic streptococci can be grown oln culture from the patient's blood. It has already been pointed out that if the few cubic centimetres of bloodl required for culture demonstrate the presence of ha,molytic streptococci, how great must be the magnitude of the general septicimia present. At this stage the streptococci multiply at an alarming pace in the circulation and elaborate their toxins freely. Consequently, the phagocytic value of the leucocytes, in which the polymorphs figure prominently, becomes negatived by the steadily increasing army of hoemolytic streptococci.
In results attributed to an early dose of anti-scarlatinal serum are really due to the serum administered, and how may we know that such results would not have occurred apart from any treatment, since there are cases on record where recovery has taken place 'naturally'?" Now, in the foregoing question, there is implied the fact that in certain patients' blood there is present a sufficient quantity of streptococcal antitoxin to neutralize exotoxins produced by hxmolytic streptococci-an implication which indicates the great importance of such antitoxin as an antagonist to puerperal streptococcal sepsis. It is here that the importance of anti-scarlatinal serum comes in, for since it is a streptococcus haemolyticus antitoxin itself, its administration will serve either to compensate for antitoxin deficiency in the patient concerned, or, should antitoxin be already present in any quantity, to augment it. The more antitoxin, the less toxaemia. Now, to show that an early dose of anti-scarlatinal serum is responsibe for the good results attributed to it, one has only to compare the "pre-serum" condition of a patient who is injected early in the disease with the "post-serum" condition. To begin with, if the illness is at all severe, it is very improbable that the quantity of streptococcal antitoxin present in the blood is great, and if the condition of the patient twenty-four hours after serum administration shows a definite and generally progressive change for the better, I do not think it is claiming too much to say that the serum administered deserves the credit. This claim is further enhanced with a negative history of scarlatina.
Again, in my experience individual prognosis in puerperal streptococcal sepsis is often extremely difficult where anti-scarlatinal serum has not been administered reasonably early. Statistics form the most reliable guide, and from my own on next page it will be seen how greatly diminished was the death-rate, with antiscarlatinal serum treatment, among patients suffering from puerperal septic infection (streptococcus haemolyticus) at Belfast Infirmary during the year 1930, the first complete year in which we tried the antitoxin in question. Hence, in view of the beneficial action of this serum as a neutralizer of haemolytic streptococcus exotoxins, and in view of the marked reduction that I have seen in the number of deaths from puerperal streptococcal sepsis with this serum, I can honestly recommend it as a most valuable method of treatment and well worthy of our perseverance.
One point remains to be emphasized. Anti-scarlatinal serum, to be really effective, must be administered early in the disease. It is lamentable to hear, as I have done, an indifferent opinion expressed upon its worth on the basis of results obtained from fourth-and fifth-day administrations. Failure in such instances is due to lateness and not incompetency. What would be the results with anti-diphtheritic serum if it were employed as late in diphtheria? The death-rate in that disease would certainly not remain at its present level. Hence, since diphtheria, where the toxin alone enters the blood-stream, merits due respect by early serum administration, should not puerperal (haemolytic) streptococcal sepsis merit equal respect when we know that the infecting organisms are themselves very likely to invade the circulation in addition to their toxins, and rapidly multiply therein, if treatment is not commenced in time? 97
I should like to emphasize the fact that a negative blood-culture does not in itself exclude a diagnosis of septiceemia. Very frequently a positive result indicates an advanced stage of the disease, when little can be expected from any form of treatment.
In conclusion, I wish to make it clear that I do not claim that anti-scarlatinal serum constitutes a specific for the disease under consideration. What I do claim is that it represents by far the most effective method of treatment which we have at our disposal to-day.
STATISTICS.
During the year 1930, the total number of cases (intern and extern) admitted to the isolation department for puerperal septic cases was twenty-seven. Of these, twenty-two had haemolytic streptococci present in the intra-uterine swab, plus the accompaniments of streptococcal infection. In some cases the latter were more marked than in others, but in all they were quite definite. The death-rate among these cases, all of which received the anti-scarlatinal serum treatment, was only 4.54 per cent., or 1 out of 22. Since one other streptococcal case, excessively virulent, admitted before the beginning of the year, died, the total death-rate among puerperal hamolytic streptococcal cases for the year 1930 stands at the small percentage of 8.7 (to the nearest decimal point), or 2 out of 23. The large majority of the cases received the serum in good time, which is mainly responsible for the fact that only seven of them required a repeat dose. MEDICAL benefit in Northern Ireland has now entered on its third year, and, in spite of the gloomy prophecies of some of the pessimists both in and out of the profession, there would now appear to be almost a consensus of opinion that the scheme represents a distinct advance in our medical services, both from the point of view of the patients and that of the practitioners. SCOPE OF SERVICE.-Stated briefly, it is a general practitioner service, but insurance practitioners may, if they can show that they possess special skill and experience, carry out and charge for certain services usually undertaken only by specialists. In this connection it should be remembered that the following declaration has to be made: "I have so informed the insured person, who has agreed that I should render the service as a matter of special arrangement. " It is hardly necessary to add that no part of the medical fund is available for specialist services.
If an operation is performed as an emergency, it does not follow that you are entitled to regard the service as being "outside the scope." 98
